Literature DB >> 29422666

Response to: 'Comment on: 'How to defuse a demographic time bomb: the way forward?'

John C Buchan1, Winfried Amoaku2, Beth Barnes3, Andy Cassels-Brown4, Bernard Y Chang4, Jane Harcourt5, Darren Shickle6, Anne Fiona Spencer7, Stephen A Vernon8, Carrie MacEwen9.   

Abstract

Mesh：

Year:  2018        PMID： 29422666      PMCID： PMC5997643          DOI： 10.1038/s41433-017-0013-z

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  7 in total

Review 1.  Is it time for a new attitude to "simultaneous" bilateral cataract surgery?

Authors:  G T Smith; C S Liu
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

2.  Simultaneous bilateral endophthalmitis after immediate sequential bilateral cataract surgery: what's the risk of functional blindness?

Authors:  Andrew P Schachat
Journal:  Am J Ophthalmol       Date:  2014-08       Impact factor: 5.258

3.  The -174G/C interleukin-6 promoter polymorphism influences the development of macular oedema following uncomplicated phacoemulsification surgery.

Authors:  I Masood; A Negi; S A Vernon; P Comeglio; A H Child
Journal:  Eye (Lond)       Date:  2006-10-06       Impact factor: 3.775

4.  Risk Factors and Incidence of Macular Edema after Cataract Surgery: A Database Study of 81984 Eyes.

Authors:  Colin J Chu; Robert L Johnston; Charlotte Buscombe; Ahmed B Sallam; Queresh Mohamed; Yit C Yang
Journal:  Ophthalmology       Date:  2015-12-08       Impact factor: 12.079

5.  Simultaneous bilateral intraocular surgery.

Authors:  P J Fenton; I D Gardner
Journal:  Trans Ophthalmol Soc U K       Date:  1982-07

Review 6.  Immediate Sequential Bilateral Cataract Surgery: A Systematic Review and Meta-Analysis.

Authors:  Line Kessel; Jens Andresen; Ditte Erngaard; Per Flesner; Britta Tendal; Jesper Hjortdal
Journal:  J Ophthalmol       Date:  2015-08-17       Impact factor: 1.909

7.  Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo.

Authors:  Sean McCafferty; April Harris; Corin Kew; Tala Kassm; Lisa Lane; Jason Levine; Meisha Raven
Journal:  BMC Ophthalmol       Date:  2017-02-20       Impact factor: 2.209
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.